Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT06885775
Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds (DXP01)
A Multicenter, Randomized, Evaluator- and Subject-blinded, Active-controlled, Paired, Confirmatory Clinical Trial to Compare and Evaluate the Efficacy and Safety of DXP01 Versus Juvéderm® ULTRA 3 in Adults Requiring the Temporary Improvement of Moderate to Severe Nasolabial Folds
Sponsor: DEXLEVO
Conditions
Dermal Fillers Nasolabial Folds, Wrinkles
Interventions
DXP01 Juvederm ULTRA 3
Updated 1 time since 2025 Last updated: Mar 13, 2025 Started: Apr 28, 2025 Primary completion: Apr 1, 2027 Completion: Dec 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Dermal Fillers and Nasolabial Folds, Wrinkles, this trial is actively recruiting participants. The trial is conducted by DEXLEVO and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- DEXLEVO
Data source: DEXLEVO
For direct contact, visit the study record on ClinicalTrials.gov .